viroporin
serv
highli
divers
function
viral
infect
cycl
illustr
fig
earli
studi
viroporin
focus
system
includ
polioviru
togaviru
influenza
viru
wellknown
viroporin
modifi
membran
permeabl
allow
passag
ion
small
molecul
later
stage
viral
infect
small
hydrophob
acyl
protein
shown
form
cationselect
channel
insert
lipid
bilay
propos
involv
viru
bud
exact
role
viral
life
cycl
poorli
character
proton
channel
studi
viroporin
drug
target
first
antiflu
drug
amantadin
rimantadin
one
smallest
proton
channel
proton
select
motif
found
proton
channel
organ
sinc
definit
viroporin
put
forward
viroporin
classifi
tabl
influenza
b
viru
encod
proton
channel
function
homolog
block
adamantan
famili
drug
human
immunodefici
viru
type
vpu
hepat
c
viru
hcv
shown
form
oligomer
channel
conduct
cation
protein
enteroviru
howev
display
alter
channel
activ
conduct
anion
eg
instead
cation
paramecium
bursaria
chlorella
viru
viral
k
channel
name
kcv
contain
canon
potassium
select
filter
propos
adopt
similar
structur
kcsa
addit
ion
channel
rhinoviru
form
pore
allow
singlestrand
viral
rna
cross
membran
expand
list
substrat
viroporin
transport
probabl
bestdefin
role
viroporin
proton
channel
influenza
b
virus
involv
equilibr
ph
compart
one
import
role
equilibr
ph
across
viral
membran
viral
entri
acidifi
virion
interior
immedi
endocytosi
facilit
rna
releas
fig
anoth
role
equilibr
ph
across
transgolgi
membran
infect
cell
viral
matur
preserv
prefus
form
hemagglutinin
fusion
protein
deacidif
golgi
lumen
fig
role
cationselect
viroporin
less
clear
one
gener
role
propos
viroporin
depolar
either
er
plasma
membran
facilit
membran
curvatur
format
viru
bud
fig
case
hcv
exampl
channel
activ
report
facilit
viru
releas
anoth
gener
role
viroporin
simpli
caus
cation
leakag
would
induc
cellular
stress
program
cell
death
fig
addit
ion
permeat
sever
viroporin
known
particip
viral
assembl
interact
protein
exampl
influenza
protein
signific
cytoplasm
domain
believ
recruit
matrix
protein
viru
assembl
hcv
protein
also
report
interact
nonstructur
protein
interact
appear
crucial
product
infecti
hcv
particl
envelop
virus
infect
host
cell
fusion
viral
cellular
membran
depend
type
viru
fusion
occur
either
host
plasma
membran
endosom
membran
membran
fusion
must
occur
without
consum
energi
catalyz
major
conform
chang
special
envelop
protein
gener
known
viral
fusion
protein
despit
divers
known
viral
fusion
protein
convert
prefus
state
dimer
trimer
depend
class
key
intermedi
state
extend
conform
postfus
state
trimer
hairpin
bring
fusion
peptid
attach
target
membran
tm
domain
attach
viral
membran
close
proxim
therebi
facilit
fusion
viral
target
membran
fig
three
distinct
class
viral
fusion
protein
exemplifi
fig
defin
base
structur
criteria
class
includ
fusion
protein
best
character
human
pathogen
influenza
protein
trimer
singl
chain
precursor
requir
proteolyt
cleavag
gener
two
fragment
exampl
influenza
hemagglutinin
ha
contain
ntermin
fragment
ctermin
fragment
envelop
protein
cleav
fragment
fusogen
fragment
bear
hydrophob
fusion
peptid
cap
outer
receptor
bind
fragment
receptor
bind
accompani
cap
protein
releas
allow
major
conform
chang
ultim
lead
fusion
case
influenza
cap
releas
low
ph
endosom
endocytosi
class
ii
fusion
protein
found
flavivirus
alphavirus
bunyavirus
e
flavivirus
alphavirus
gn
gc
bunyavirus
although
fusion
protein
architectur
differ
class
fusion
protein
ie
class
ii
fusion
protein
mostli
made
oppos
helic
structur
class
fusion
protein
oper
physic
principl
fusion
peptid
form
loop
tip
serv
anchor
insert
host
membran
endocytosi
unlik
class
protein
remain
trimer
conform
chang
involv
chang
oligomer
state
prefus
dimer
postfus
trimer
reduc
ph
endosom
induc
cascad
subsequ
refold
trimer
event
achiev
membran
fusion
member
class
iii
includ
g
protein
vsv
gb
herp
simplex
viru
epsteinbarr
viru
ebv
insectcel
baculoviru
class
iii
fusion
protein
combin
featur
class
ii
fusion
protein
protom
compos
five
domain
contain
central
trimer
coiledcoil
hallmark
class
protein
postfus
state
three
domain
predominantli
made
fusion
peptid
close
resembl
class
ii
protein
fusion
loop
found
tip
extend
due
essenti
role
viral
fusion
protein
infect
long
pursu
target
antivir
intervent
exampl
approv
small
molecul
drug
arbidol
use
broadspectrum
inhibitor
influenza
b
viru
well
hepat
c
viru
unlik
mani
broadspectrum
antivir
arbidol
establish
mechan
action
influenza
b
virus
involv
inhibit
virusmedi
membran
fusion
thu
viral
entri
addit
enfuvirtid
fuzeon
approv
peptid
drug
block
entri
deriv
ctermin
heptad
repeat
region
envelop
glycoprotein
design
cpeptid
disrupt
membran
fusion
compet
intramolecular
interact
import
refold
membran
fusion
apart
therapeut
target
anoth
import
medic
use
fusion
protein
vaccin
develop
viral
fusion
protein
usual
present
virion
surfac
high
copi
number
thu
popular
antigen
elicit
broadspectrum
neutral
antibodi
exampl
nativ
conform
envelop
glycoprotein
pursu
intens
immunogen
bcell
base
vaccin
develop
singlepass
tm
protein
role
tmd
beyond
membran
anchor
unresolv
partli
difficulti
structur
studi
notori
resist
crystal
due
small
size
unfeas
visual
cryoelectron
microscopi
em
exampl
crystal
structur
small
tmd
includ
tmd
recent
crystal
structur
tm
helix
dimer
glycophorin
protein
cryoem
rapidli
approach
atom
resolut
becom
increasingli
use
examin
structur
much
larger
viral
fusion
protein
contain
tmd
notabl
recent
cryoem
studi
envelop
glycoprotein
env
includ
tmd
achiev
high
resolut
structur
prefus
state
env
studi
howev
show
tmd
membraneproxim
region
env
disord
possibl
due
incompat
membraneassoci
region
env
deterg
use
solubil
env
chapter
mainli
focu
use
nmr
studi
tm
membraneproxim
region
viral
membran
protein
includ
method
structur
determin
investig
drug
bind
first
challeng
nmr
studi
prepar
suffici
quantiti
isotop
label
protein
trivial
small
hydrophob
protein
robust
approach
forc
highlevel
express
hydrophob
peptid
toxic
cell
inclus
bodi
experi
effect
implement
approach
express
peptid
ctermin
fusion
trple
protein
drive
inclus
bodi
format
vector
fig
trple
ntermin
tag
permit
nickel
affin
purif
methionin
trple
peptid
ad
cleavag
cyanogen
bromid
peptid
releas
trple
purif
peptid
involv
purifi
trplepeptid
fusion
protein
inclus
bodi
nickel
affin
cleavag
cyanogen
bromid
fusion
protein
formic
acid
separ
peptid
trple
fusion
protein
reversephas
hplc
protocol
quit
gener
hydrophob
peptid
requir
peptid
methionin
middl
peptid
sequenc
nativ
methionin
mutat
altern
method
use
solubl
fusion
domain
eg
maltos
bind
protein
specif
proteas
cleavag
site
releas
peptid
purifi
hydrophob
peptid
reconstitut
membran
mimet
media
includ
deterg
micel
bicel
lipid
nanodisc
nanodisc
closest
mimic
nativ
membran
find
lipiddeterg
bicel
system
good
compromis
capac
provid
near
lipid
bilay
environ
gener
good
nmr
spectra
previou
studi
bicel
system
dmpc
lipid
dhpc
deterg
shown
molar
ratio
lipid
deterg
q
assembl
reach
ideal
bicel
condit
lipid
deterg
well
segreg
q
exampl
estim
diamet
lipid
bilay
region
bicel
disc
accord
equat
describ
bicel
assembl
size
suffici
larg
accommod
small
tmd
remark
even
bicel
size
could
gener
nmr
spectra
suffici
high
qualiti
enabl
fullscal
structur
determin
demonstr
structur
determin
trimer
tmd
fa
death
receptor
env
provid
exampl
bicel
reconstitut
previou
studi
tmd
env
hydrophob
peptid
lyophil
first
complet
dissolv
strong
organ
solvent
eg
hexafluoroisopropan
calcul
amount
dmpc
solut
slowli
dri
thin
film
nitrogen
stream
dri
film
dissolv
urea
contain
calcul
amount
dhpc
denatur
remov
dialysi
dmpc
dhpc
ratio
monitor
nmr
loss
dhpc
dialysi
compens
addit
dhpc
owe
small
size
tmd
viral
membran
protein
structur
determin
nmr
normal
straightforward
probabl
biggest
challeng
measur
interprotom
restraint
case
oligom
complex
particular
structur
determin
symmetr
oligom
face
challeng
measur
noebas
distanc
structur
equival
protom
nmr
peak
need
interprotom
restraint
proven
way
solv
problem
use
mix
sampl
half
protom
label
half
measur
exclus
noe
one
protom
neighbor
protom
exampl
tmd
fa
receptor
shown
fig
trimer
solut
establish
convent
edit
noe
experi
use
collect
selfconsist
backbonesidechain
sidechainsidechain
noe
restraint
addit
structur
determin
import
aspect
small
tmd
interact
membran
bicel
system
allow
accur
determin
posit
tmd
bilay
region
bicel
use
solvent
paramagnet
relax
enhanc
pre
analysi
method
titrat
watersolubl
membraneinaccess
paramagnet
agent
gddota
gadolinium
iii
use
gener
solvent
pre
approach
base
notion
bicel
suffici
wide
later
solvent
pre
becom
neglig
thu
allow
use
measur
solvent
pre
probe
residuespecif
depth
immers
protein
along
bicel
normal
titrat
point
correl
spectrum
record
measur
residuespecif
pre
residu
pre
titrat
curv
fit
exponenti
decay
deriv
residuespecif
pre
amplitud
preamp
preamp
vs
residu
posit
along
trimer
symmetri
axi
parallel
bilay
normal
analyz
use
sigmoid
fit
method
determin
tmd
region
resid
center
bilay
well
thick
bilay
around
protein
studi
small
molecul
drug
bind
viral
membran
protein
chemic
shift
perturb
csp
induc
drug
titrat
conveni
probe
identifi
approxim
bind
site
caution
need
taken
due
complic
associ
membranemimet
media
first
mani
small
molecul
inhibitor
hydrophob
preferenti
partit
deterg
micel
lipiddeterg
bicel
thu
csp
induc
simpli
alter
micellebicel
environ
second
addit
csp
caus
close
ligand
contact
csp
could
aris
chang
conform
andor
dynam
henc
direct
noe
data
prefer
wherev
feasibl
simplest
sensit
approach
collect
proteindrug
noe
use
protein
complet
deuter
noe
protein
backbon
amid
proton
drug
proton
could
measur
unambigu
fig
bind
site
unambigu
spot
contact
drug
protein
sidechain
measur
use
convent
methyl
aromat
noesi
detail
experi
describ
studi
identifi
drug
bind
site
influenza
hcv
channel
influenza
influenza
b
singlepass
membran
protein
respect
form
homotetram
membran
sequenc
consist
three
domain
extracellular
ntermin
domain
transmembran
domain
tmd
intracellular
ctermin
domain
domain
arrang
differ
structur
homolog
sequenc
two
protein
hxxxw
sequenc
motif
tmd
essenti
channel
activ
tm
region
contain
residu
unstructur
extracellular
segment
rel
conserv
sought
vaccin
epitop
similar
size
tmd
residu
much
larger
ctermin
cytoplasm
domain
cytoplasm
region
also
assembl
oligom
import
recruit
matrix
protein
cell
surfac
viral
assembl
first
highresolut
structur
channel
report
concurr
solut
nmr
spectroscopi
xray
crystallographi
subsequ
xray
solut
nmr
studi
also
determin
structur
differ
condit
differ
drug
resist
mutat
moreov
structur
character
solidst
nmr
studi
gener
channel
structur
lipid
bilay
environ
structur
solv
differ
condit
show
significantli
differ
conform
fig
suggest
tetramer
assembl
quit
dynam
sensit
reconstitut
environ
structur
plastic
observ
like
present
mani
viral
membran
protein
could
explain
structur
studi
type
protein
difficult
despit
differ
experiment
structur
converg
common
mode
channel
assembl
lefthand
fourhelix
bundl
form
channel
pore
tetramer
four
tm
helic
stabil
intermolecular
contact
ctermin
amphipath
helic
flank
tmd
mode
assembl
place
h
w
hxxxw
sequenc
motif
insid
channel
fig
four
imidazol
ring
phgate
featur
essenti
transport
proton
pack
close
insid
pore
fig
moreov
pack
indol
creat
channel
gate
occlud
ctermin
end
pore
structur
channel
solv
use
solut
nmr
method
although
overal
assembl
tmd
similar
tmd
ie
show
lefthand
helic
pack
two
differ
substanti
detail
fig
unlik
channel
show
strong
coiledcoil
characterist
regular
heptad
repeat
structur
two
heptad
repeat
show
posit
occupi
mostli
hydrophil
residu
serin
posit
g
e
occupi
hydrophob
leucin
phenylalanin
respect
allow
peripher
hydrophob
interact
leucin
phenylalanin
fig
arrang
coiledcoil
assembl
membran
allow
tm
segment
form
stabl
tetram
opposit
watersolubl
coiledcoil
tetram
posit
typic
hydrophob
residu
posit
g
e
polar
residu
histidin
tryptophan
hxxxw
motif
also
porelin
invers
coiledcoil
assembl
membran
cytoplasm
domain
also
oligomer
lefthand
coiledcoil
tetram
watersolubl
show
strong
bipolar
distribut
surfac
charg
charg
domain
support
interact
matrix
protein
structur
arrang
histidin
tryptophan
insid
pore
suggest
two
residu
play
essenti
role
channel
select
channel
gate
fig
function
mutagenesi
nmr
measur
show
proton
transport
across
membran
channel
involv
cycl
histidin
proton
deproton
histidin
serv
proton
shuttl
devic
histidin
proton
time
narrow
channel
proton
one
histidin
would
increas
energi
barrier
proton
anoth
histidin
inde
multipl
pka
valu
one
detect
therefor
current
understand
proton
conduct
mechan
minim
requir
unit
phdepend
proton
conduct
histrp
complex
propos
ref
nonconduct
state
two
pair
histidin
tetram
share
one
proton
explain
high
pka
lower
ph
result
proton
third
histidin
ntermin
side
turn
disrupt
two
histidin
dimer
lead
proton
conduct
state
also
propos
proton
histidin
lead
interact
histidin
tryptophan
remain
question
address
third
proton
affect
tryptophan
conform
allow
proton
relay
ctermin
side
tryptophan
gate
viroporin
encod
hcv
genom
protein
oligomer
membran
form
cationselect
channel
higher
select
kna
channel
activ
import
assembl
releas
infecti
virus
although
molecular
mechan
function
remain
unknown
case
structur
character
confront
challeng
cope
hydrophob
dynam
natur
protein
earlier
nmr
studi
condit
support
monomer
state
protein
show
three
tm
helic
segment
two
ntermin
half
sequenc
one
near
cterminu
although
monomer
state
conduct
ion
could
involv
interact
protein
viru
assembl
oligomer
form
first
examin
use
singleparticl
em
show
hcv
genotyp
strain
assembl
hexam
micel
complex
adopt
flowerlik
shape
resembl
known
ion
channel
structur
databas
later
detail
structur
hexam
determin
solut
nmr
use
genotyp
strain
reconstitut
dodecylphosphocholin
dpc
micel
consist
flowershap
em
imag
nmr
structur
show
funnellik
architectur
six
minimalist
chain
contain
three
helic
segment
form
narrow
wide
region
funnelshap
caviti
respect
helic
wrap
channel
peripher
interact
fig
assembl
strategi
adopt
differ
significantli
known
channel
bacteria
eukaryot
ion
channel
typic
two
essenti
featur
pore
element
support
select
ion
dehydr
gate
constrict
prevent
nonspecif
permeat
open
respons
regul
factor
ph
voltag
ligand
ion
select
channel
interior
number
strongli
conserv
residu
like
candid
serv
function
one
suspect
form
ring
carboxamid
near
narrow
end
channel
fig
residu
asparagin
strain
except
substitut
histidin
genotyp
virus
format
ring
carboxyl
carboxamid
recur
theme
prokaryot
eukaryot
channel
select
dival
cation
exampl
cora
channel
pentamer
ring
asparagin
calcium
releaseactiv
calcium
crac
channel
orai
hexamer
ring
aspart
acid
channel
strong
select
dival
cation
although
also
conduct
monoval
cation
na
k
addit
ring
residu
near
hing
arrang
may
also
bind
cation
fig
although
residu
yet
test
function
assay
addit
appear
cation
select
ring
near
narrow
ntermin
exit
channel
wider
ctermin
entranc
channel
decor
conserv
ring
arginin
lysin
fig
placement
posit
charg
ring
entranc
anticip
may
repel
cation
earlier
studi
report
design
tm
barrel
intern
argininehistidin
dyad
form
effici
cation
select
channel
immobil
arginin
recruit
mobil
anion
turn
facilit
cation
diffus
pore
interest
note
highli
basic
region
contain
pore
also
found
crac
orai
structur
one
possibl
role
basic
residu
cation
select
channel
bind
obstruct
anion
allow
cation
diffus
pore
mechan
would
consist
observ
replac
neg
charg
aspart
acid
larg
abrog
conduct
still
mani
unansw
question
nmr
structur
solv
absenc
inhibitor
repres
open
close
state
channel
two
state
exist
strong
select
develop
gener
unspecif
cation
channel
purpos
dissip
membran
potenti
exampl
anoth
recent
studi
report
activ
dissip
proton
gradient
within
cell
membran
compart
unclear
ion
flux
mediat
play
domin
role
hcv
life
cycl
structur
perspect
funnellik
architectur
form
multipl
helic
segment
connect
hing
short
loop
believ
flexibl
afford
dynam
open
close
tip
channel
probabl
intrigu
aspect
small
molecul
interact
viroporin
find
adamantan
deriv
amantadin
rimantadin
inhibitori
effect
multipl
viroporin
includ
influenza
hcv
amantadin
symadin
rimantadin
flumadin
first
licens
drug
treat
influenza
infect
fact
compound
also
play
critic
role
earli
day
function
character
channel
channel
function
structur
homolog
sensit
adamantan
famili
drug
remark
hcv
channel
structur
complet
differ
show
detect
though
strong
sensit
rimantadin
mechan
amantadinerimantadin
inhibit
channel
elus
quit
time
previou
confus
came
mainli
multipl
bind
site
observ
experiment
crystallograph
studi
tmd
residu
presenc
amantadin
drug
densiti
found
insid
channel
near
residu
structur
resolut
difficult
confirm
posit
amantadin
bind
time
howev
solut
nmr
studi
longer
version
residu
show
rimantadin
bind
extern
lipidfac
pocket
around
residu
adjac
tm
helic
two
differ
bind
site
obvious
suggest
differ
mechan
inhibit
one
drug
directli
block
channel
passag
drug
bind
extern
site
alloster
favor
close
state
channel
subsequ
solidst
nmr
measur
lipid
bilay
show
site
exist
higher
affin
intern
site
strongest
evid
intern
site
primari
site
drug
action
came
function
studi
use
chimera
protein
studi
author
construct
chimera
variant
influenza
b
virus
contain
intern
site
show
chimera
channel
still
amantadin
sensit
indic
intern
site
primari
site
drug
inhibit
later
complex
structur
tmd
chimera
rimantadin
determin
solut
nmr
provid
detail
view
drug
bind
insid
channel
pore
drug
bind
site
consist
eight
methyl
group
tetram
two
subunit
form
deep
intern
hydrophob
pocket
surround
adamantan
cage
drug
fig
structur
also
show
nitrogen
rimantadin
amino
group
may
form
hydrogen
bond
backbon
carbonyl
oxygen
one
four
subunit
termin
methyl
group
rimantadin
middl
pore
face
open
space
channel
around
posit
structur
also
show
rimantadin
bind
slightli
tilt
vertic
axi
averag
symmetri
axi
channel
tilt
angl
consist
amantadin
tilt
channel
observ
solidst
nmr
spectroscopi
addit
block
channel
amantadin
deriv
also
shown
pose
inhibitori
effect
channel
conduct
physic
bind
site
amantadin
rimantadin
identifi
genotyp
use
intermolecular
noe
experi
noe
data
reveal
amantadin
rimantadin
bind
six
equival
hydrophob
pocket
due
sixfold
symmetri
channel
poreform
peripher
helic
fig
site
appear
form
hydrophob
pocket
wrap
around
adamantan
cage
drug
amino
group
amantadin
rimantadin
face
larg
hydrophil
channel
lumen
import
properti
drug
bind
site
consist
element
differ
helic
segment
differ
monom
ration
permeat
cation
channel
may
depend
open
narrow
end
funnel
turn
depend
reorient
helic
segment
bind
adamantan
deriv
pocket
may
inhibit
channel
activ
alloster
caus
channel
close
inde
nmr
relax
dispers
studi
show
residu
hing
narrow
end
caviti
experienc
substanti
chemic
exchang
excit
state
data
consist
movement
helic
caus
tip
funnel
open
close
importantli
addit
rimantadin
slow
motion
tip
channel
relax
dispers
curv
signific
chemic
exchang
apo
state
complet
flat
drugbound
state
dispers
curv
also
significantli
flatter
individu
curv
fit
yield
kex
valu
clearli
rimantadin
bind
make
channel
less
dynam
therefor
rimantadin
may
thu
act
molecular
wedg
prevent
dynam
breath
channel
requir
ion
conduct
compar
amantadin
rimantadin
bind
mode
hcv
influenza
show
two
fundament
differ
mechan
drug
inhibit
case
one
drug
bind
one
channel
drug
bind
inhibit
proton
transport
directli
block
channel
passag
also
prevent
channel
open
case
amantadin
rimantadin
clearli
small
block
channel
instead
bind
six
equival
site
outsid
channel
caviti
afford
six
drug
per
channel
rimantadin
bind
site
relev
inhibit
crude
suggest
previou
function
mutagenesi
drug
bind
site
inhibit
cation
conduct
alloster
mechan
possibl
stabil
close
state
channel
although
mechan
drug
inhibit
may
complet
differ
structur
base
govern
drugbind
affin
actual
similar
involv
hydrophob
size
pocket
posit
drug
amino
group
fig
case
tetram
drug
adamantan
cage
fit
snuggli
hydrophob
pocket
form
eight
methyl
group
two
subunit
drug
amino
group
form
polar
contact
backbon
oxygen
point
polar
region
channel
caviti
channel
adamantan
cage
contact
ten
methyl
group
aromat
group
protein
hydrophob
group
form
deep
hydrophob
pocket
also
match
close
size
adamantan
cage
amino
group
amantadin
rimantadin
point
channel
lumen
posit
form
polar
contact
electroneg
group
backbon
carbonyl
residu
henc
greasi
pocket
adamantan
cage
nearbi
electroneg
group
interact
amino
group
may
gener
requir
amantadin
rimantadin
bind
envelop
spike
env
trimer
cleav
type
membran
protein
fuse
viral
host
cell
membran
initi
viral
infect
receptor
recognit
membran
fusion
protein
respect
conform
chang
trigger
bind
receptor
coreceptor
eg
lead
cascad
refold
event
similar
illustr
fig
ultim
membran
fusion
matur
function
env
spike
sole
antigen
virion
surfac
thu
import
candid
vaccin
develop
nativ
prefus
conform
env
recogn
broadli
neutral
antibodi
bnab
gener
believ
potenti
induc
antibodi
respons
thu
nativ
conform
env
spike
surfac
virion
extrem
import
immunogen
design
bcell
base
vaccin
develop
vast
amount
structur
ectodomain
ecd
complex
determin
rel
littl
known
tm
membran
proxim
region
due
challeng
preserv
nativelik
fold
region
membran
mimet
media
shown
truncat
cytoplasm
tail
ct
could
alter
antigen
surfac
env
ecd
opposit
side
membran
suggest
ecd
tmd
membran
proxim
region
conform
coupl
thu
conform
stabil
tmd
import
consider
immunogen
design
bcell
base
vaccin
develop
recent
nmr
structur
tmd
solv
bicel
made
dmpc
lipid
dhpc
deterg
q
use
fragment
residu
clade
isol
design
tmd
form
wellstructur
trimer
almost
helic
way
n
ctermin
end
show
two
peculiar
featur
seen
known
oligomer
tm
helic
tmh
fig
one
unusu
featur
tmd
trimer
appear
stabil
two
separ
pack
mode
fig
ntermin
half
encompass
gxxxg
motif
form
coiledcoil
trimer
wherea
ctermin
half
held
togeth
network
polar
contact
name
hydrophil
core
ntermin
coiledcoil
helic
wheel
represent
trimer
clearli
indic
pack
hydrophob
residu
ile
val
posit
heptad
motif
form
hydrophob
core
gxxxg
wellknown
motif
drive
tmh
dimer
classic
exampl
glycophorin
tmd
dimer
structur
two
glycin
one
tmh
allow
close
pack
gxxxg
face
anoth
tmh
result
strong
tmh
dimer
complex
previou
report
howev
gxxxg
involv
tmh
trimer
coiledcoil
region
env
tmd
involv
trimer
assembl
ie
small
sidechain
allow
close
vdw
contact
adjac
tmh
glycin
peripheri
trimer
face
outward
mutat
alanin
valin
essenti
effect
tmd
trimer
well
env
function
therefor
key
differ
structur
role
gxxxg
motif
glycophorin
tmd
dimer
env
tmd
trimer
glycin
requir
form
intermonom
contact
dimer
one
glycin
import
trimer
assembl
tm
segment
mani
viral
fusion
protein
contain
gxxxg
motif
smallxxxsmal
motif
small
refer
residu
small
side
chain
glycin
alanin
serin
cystein
suggest
oligomer
tmd
may
common
properti
exampl
recent
biochem
evid
shown
tmd
hepat
c
viru
envelop
glycoprotein
form
stabl
dimer
trimer
also
resist
sd
highresolut
structur
tmd
oligom
viral
fusion
protein
report
due
technic
challeng
structur
studi
construct
context
lipid
bilay
nmr
structur
env
tmd
may
provid
clue
viral
fusion
protein
oligomer
membran
anoth
peculiar
featur
presenc
three
copi
arginin
near
middl
tmh
fig
suggest
three
unbalanc
charg
hydrophob
core
membran
arg
remain
proton
nmr
structur
tip
long
sidechain
arginin
face
lipid
surround
three
hydrophob
residu
also
interest
note
occupi
posit
coiledcoil
face
inward
trimer
interfac
precis
physic
basi
accommod
highli
hydrophob
environ
remain
unclear
underli
mechan
must
toler
ly
residu
present
viral
isol
posit
interest
mention
noe
experi
epsilon
proton
show
clear
water
noe
even
short
noe
mix
time
ms
suggest
arg
somehow
hydrat
membran
positivelycharg
arg
ly
tm
segment
viral
fusion
protein
present
relat
envelop
virus
includ
simian
immunodefici
viru
caprin
arthriti
enceph
viru
equin
infecti
anemia
viru
visna
viru
foami
viru
well
hepat
c
viru
absent
mani
other
therefor
prerequisit
viral
membran
fusion
gener
function
mutagenesi
indic
mutant
env
show
defect
cellcel
fusion
could
fulli
compens
high
env
express
moreov
mutant
wildtyp
viral
infect
vitro
infect
cellcel
fusion
howev
mimic
condit
viru
move
one
cell
anoth
infect
individu
assay
particularli
sensit
physiolog
relev
kinet
paramet
structur
viroporin
discuss
substanti
differ
channel
structur
found
prokaryot
eukaryot
thu
clean
structur
target
develop
antivir
compound
avail
structur
also
suggest
viroporin
gener
adopt
minimalist
architectur
possess
structur
featur
compat
select
ion
transport
viral
channel
howev
may
function
robust
specif
regul
counterpart
prokayrot
eukaryot
virus
often
need
intric
regul
channel
activ
infect
cycl
minimalist
structur
also
make
viroporin
fragil
sensit
membran
environ
reflect
conform
variat
observ
channel
differ
reconstitut
media
therefor
remain
import
examin
viroporin
nativ
environ
eg
lipid
bilay
fulllength
protein
solidst
nmr
continu
improv
spectral
resolut
obtain
detail
structur
viroporin
liposom
principl
feasibl
near
futur
altern
ideal
bicel
system
explor
solut
nmr
revisit
viroporin
structur
determin
previous
deterg
micel
futur
establish
nmr
system
viroporin
nativ
condit
would
certainli
provid
versatil
effect
platform
investig
inhibitor
bind
apart
progress
structur
determin
major
challeng
lie
ahead
function
aspect
viroporin
research
precis
function
role
mani
viroporin
still
unclear
moreov
due
lack
robust
singlechannel
record
setup
suitabl
viroporin
ion
conduct
properti
viroporin
fulli
character
therefor
better
definit
function
role
channel
properti
viroporin
certainli
draw
greater
enthusiasm
develop
therapeut
target
interest
famili
membran
channel
exampl
env
suggest
tmd
viral
fusion
protein
adopt
interest
structur
distinct
structur
featur
certainli
allud
role
viral
fusion
protein
assembl
incorpor
envelop
well
process
membran
fusion
nmr
structur
studi
tmd
bicel
q
demonstr
structur
viral
fusion
protein
tmd
principl
determin
essenti
lipid
bilay
environ
use
modern
nmr
techniqu
moreov
combin
use
ideal
bicel
q
solvent
paramagnet
relax
enhanc
measur
use
determin
membran
partit
tmd
bilay
region
bicel
believ
next
major
challeng
lie
understand
role
fusion
protein
tmd
fusion
mechan
case
flu
ha
hiv
exampl
new
experi
need
design
address
question
tmd
interact
fusion
domain
hemifus
stage
two
domain
presum
close
proxim
tmd
play
role
facilit
convers
hemifus
pore
format
understand
structur
properti
conform
stabil
tmd
may
also
far
reach
implic
vaccin
develop
recogn
least
mention
truncat
ct
env
could
drastic
alter
sensit
env
ecd
known
trimerspecif
bnab
continu
structur
n
c
termin
end
env
tmd
observ
nmr
suggest
env
ecd
structur
coupl
via
tmd
inde
also
shown
env
tmd
also
modul
antigen
structur
ecd
cellcel
fusion
assay
pseudovirusbas
neutral
assay
result
show
direct
correl
disrupt
tmd
trimer
led
less
inhibit
neutral
trimerspecif
bnab
target
ecd
result
suggest
stabil
tmd
trimer
import
consider
design
immunogen
hiv
vaccin
hiv
env
tmd
howev
directli
link
env
ecd
anoth
import
segment
known
membraneproxim
extern
region
mper
direct
link
connect
tmd
ecd
thu
could
principl
also
affect
antigen
properti
env
ecd
mper
sequenc
extrem
conserv
five
absolut
conserv
tryptophan
suggest
mper
probabl
also
interest
structur
featur
conform
mper
attach
tmd
trimer
lipid
bilay
environ
still
unknown
fig
previou
nmr
studi
isol
mper
peptid
deterg
micel
suggest
mper
monomer
fold
kink
helix
mani
hydrophob
residu
embed
micel
cours
would
rather
neg
implic
mper
vaccin
epitop
antibodi
bind
mper
must
dig
lipid
could
accompani
polyreact
env
tmd
appear
well
structur
assembl
strongli
trimer
henc
structur
mper
connect
trimer
tmd
context
lipid
bilay
remain
character
